Amytrx Therapeutics


Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients.

Industries

Employees

1-10

Links


Org chart

Matthew A. Gonda
President, CEO & Founder
Collapse
Randall B. Riggs
Chief Business Officer
Shima Joshi
VP, Regulatory Affairs
Danny O. Helton
VP, Chemistry & Manufacturing
Vernon L. Alvarez
SVP, Research & Development

Board & advisors



Offices